[Prospects on the Whole Cancer Genome Sequence Project]
1Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo.
Abstract:
The whole-genome sequence(WGS)has enabled us to comprehensively uncover cancer genome alterations, including non-coding drivers, structural abnormalities including fusion genes, mutation signature, and pathogenic genome integrations. Clinical utilities of WGS include effective molecular diagnosis, promotion of drug and biomarker discovery, and genome-based cancer prevention. To install WGS in the cancer medicine platform, we should establish and maintain WGS infrastructures as a sustainable system. Moreover, empirical evaluation of clinical utilities and cost-effectiveness for the target patient population is required. Furthermore, introducing new technologies such as liquid biopsy, long-read sequencing, and artificial intelligence is essential. WGS has high potentiality for next-generation genome medicine in cancer.
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Sanger Sequencing
Genomics
Cancer Survival Analysis


